Related Experiment Video
Updated: Aug 12, 2026
09:08
Multiple-mouse Neuroanatomical Magnetic Resonance Imaging
Published on: February 27, 2011
Flumazenil (Ro 15-1788) and physostigmine
1Institut für Anästhesiologie, Rheinische Friedrich-Wilhelms-Universität, Bonn, F.R.G.
Resuscitation
|January 1, 1988
Summary
Physostigmine and flumazenil can counteract benzodiazepine effects. Physostigmine acts on cholinergic mechanisms, while flumazenil targets GABAergic receptors, offering options for managing prolonged sedation or adverse reactions.
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Benzodiazepines exert pharmacologic effects via GABAergic mechanisms.
- Central anticholinergic syndrome can occur with lipophilic compounds affecting GABAergic sites.
- Physostigmine and flumazenil are antagonists for benzodiazepine effects.
Purpose of the Study:
- To review the mechanisms and clinical applications of physostigmine and flumazenil in counteracting benzodiazepine effects.
- To define indications for using these antagonists in anesthesia and intensive care settings.
Main Methods:
- Physostigmine, a choline esterase inhibitor, increases acetylcholine concentration.
- Flumazenil acts as a competitive antagonist at GABAergic sites.
- Clinical studies, EEG, and psychometric tests were used to evaluate antagonist efficacy and duration.
Main Results:
- Physostigmine onset is 2-20 min; flumazenil onset is 1-2 min.
- Flumazenil's duration of action is approximately 2 hours.
- Optimal flumazenil dose is 0.3-0.8 mg.
Conclusions:
- Physostigmine and flumazenil are effective in reversing benzodiazepine effects.
- Use should be restricted to cases of prolonged sedation or adverse effects post-anesthesia.
- In intensive care, they aid in managing high-dose benzodiazepine effects or differentiating coma causes.
Related Concept Videos
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...